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Furan-induced hepatotoxic and hematologic changes in 
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Furan forms as a result of thermal treatment of food and induces harmful effects on organisms. In our work, lycopene, 
furan, and a combination of the two were given to diabetic male rats for 28 days. Hematological changes, total protein 
and cholesterol, triglyceride, and albumin levels, alanine aminotransferase, aspartate aminotransferase, lactate 
dehydrogenase, and alkaline phosphatase activities of the serum, malondialdehyde levels, glutathione peroxidase, catalase, 
glutathione-S-transferase, superoxide dismutase activities, DNA damage in liver tissues and hepatic histopathological 
alterations were compared to a control group. There were significant changes in the liver function tests, DNA damage, 
activities of antioxidant enzymes, and malondialdehyde levels between diabetic control and non-diabetic control groups, 
between diabetic control and diabetic lycopene groups, and also between diabetic furan and diabetic control groups. In 
diabetic lycopene and diabetic furan + lycopene treated groups we designated the preventive effects of lycopene against 
diabetes and furan, however, on the analysed parameters only. In spite of some pathological alterations designated in 
diabetic furan treated group’s liver, fewer pathological alterations were observed in furan+lycopene treated groups at the 
end of week 4. Consequently, lycopene significantly reduced furan- and diabetes-induced toxicity in rat liver.
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Furan is a chemical largely used in industry. Humans 
may be exposed to it through consumption of thermally 
treated foods (1). Furan is also found in cigarette smoke 
and engine exhausts (2). It is also hepatotoxic and 
carcinogenic in animals; high incidence of cancers has been 
observed in animals, even at the lowest dose treated (1). 
Due to the prevalent use of furan, it is important to 
determine its toxic effects on organisms.
Diabetes mellitus is an endocrine disease with 
approximately 200 million people worldwide currently 
suffering from its complications (3). It causes morbidity 
and mortality due to the development of vascular 
complications like nephropathy and cardiovascular 
diseases. Owing to its quick global spread, diabetes mellitus 
is regarded as a considerable health problem (4).
Lycopene, a red–orange carotenoid pigment, has been 
examined in recent years and the results indicate that it is 
a highly effective antioxidant, possessing the capacity of 
free radical scavenging (5). It has many biochemical 
functions, some of which include antihyperlipidemic (6) 
and antiapoptotic effects (7). Recent experimental works 
have demonstrated that lycopene may prevent against 
cancers such as prostate cancer (5).
The liver is an organ that activates and detoxifies several 
chemicals. Hepatotoxicity caused by these is observed 
through the changes in the liver marker profile and 
antioxidant enzymes such as, for example, superoxide 
dismutase (SOD), catalase (CAT), aspartate aminotransferase 
(AST), alkaline phosphatase (ALP), glutathione peroxidase 
(GPx), glutathione-S-transferase (GST), and pathological 
alterations (8, 9). Therefore, these parameters have been 
largely used as biomarkers (10).
Based on other previous findings that show the effects 
of lycopene against chemical toxicity (5, 11), in this study 
we evaluated lycopene’s protective effects following furan 
exposure in diabetic rats. We investigated the parameters 
of oxidative stress (SOD, CAT, GPx, GST, MDA), 
hematological changes, liver function tests, DNA damage 
via comet assay and histopathological alterations of liver 
tissues after oral exposure to furan in diabetic rats.
MATERIALS AND METHODS
Chemicals
Furan, lycopene, streptozotocin (STZ) and all other 
chemicals were bought from Sigma-Aldrich Chemical 
Company. All chemicals used were of analytical grade. 
Lycopene and furan were dissolved in corn oil (12, 13).
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Animals and experimental design
Animals used in this study were purchased from the 
Çukurova University Experimental Research and 
Application Centre. Male Wistar rats (300-320 g) were kept 
in plastic cages at 18-22 oC, 12 h light–dark cycle, standard 
diet and water ad libitum. The rats were treated in 
accordance with the standard guide for the care and use of 
animals and the instructions given by the Çukurova 
University Animal Experiments’ Local Ethics Committee 
were followed throughout the experiment. After ten days 
of acclimatisation to the conditions of laboratory, the rats 
were divided into five groups (seven rats each) as follows:
Group I: control, received 1 mL kg-1 body weight (bw) 
corn oil 
Group II: diabetic control, received 1 mL kg-1 bw corn 
oil 
Group III: diabetic lycopene, treated with 4 mg kg-1 bw 
lycopene (13)
Group IV: diabetic furan, treated with 40 mg kg-1 bw 
furan (12)
Group V: diabetic furan+lycopene treated with 
40 mg kg-1 bw furan and 4 mg kg-1 bw lycopene
In this study, furan and lycopene were given at 
40 mg kg-1 bw and 4 mg kg-1 bw, respectively. The dose of 
furan was selected according to a previous study (12), and 
the dose of lycopene was chosen as proposed by Ateşşahin 
et al. (13). We selected these doses because Hamadeh et al. 
(12) treated rats with 40 mg kg-1 furan and evaluated gene 
expression changes. In this study we wanted to evaluate 
whether these expression changes caused pathological and 
biochemical alterations or not.
Furan and lycopene treatments were done via gavage. 
After 28 days, the animals were anesthetised with a 
combination of ketamine and xylazine and the livers were 
dissected. Blood samples were collected in tubes rinsed 
with an anticoagulant for the liver function assays of the 
serum. Liver tissues were ablated, cleaned, and washed for 
the investigations of the levels of MDA, activities of 
antioxidant enzymes, and light microscopic analyses.
Diabetes was induced in the second, third, fourth, and 
fifth groups by an injection of 55 mg kg-1 STZ 
intraperitoneally. After two days, blood samples were 
gathered from tails. Blood glucose levels were measured 
and animals with a blood glucose level of ≥300 mg dL-1 
were approved as diabetic (14).
Levels of malondialdehyde (MDA) and antioxidant 
enzyme activities
MDA levels and antioxidant enzyme activities were 
measured using a spectrophotometer (Shimadzu UV-1800, 
Kyoto, Japan). All measurements were done at +4 °C.
For analysing the levels of MDA, we relied on Ohkawa 
et al. (15). Absorbance was determined at 532 nm and 
concentrations were expressed as nmol mg protein-1.
The hepatic CAT activity was determined following the 
method of Aebi (16) by measuring the hydrolysis of 
hydrogen peroxide absorbance at 240 nm. Liver samples 
were diluted with Triton-X-100 before determination of the 
CAT activity. The CAT activity was expressed as 
mmol mg protein-1.
Marklund and Marklund’s study (17) was used for 
determining the SOD activity. For control, pyrogallol 
solution was added to Tris buffer and results were recorded 
at 440 nm. Liver extract was treated with Triton X-100. The 
sample was then added to Tris buffer and mixed. The 
reaction was started by adding pyrogallol solution. Data 
were expressed as U mg protein-1.
The GPx activity of the liver was measured using 
hydrogen peroxide as a substrate according to a study of 
Paglia and Valentine (18). The reaction was monitored at 
240 nm. The activity was expressed as nmol mg protein-1.
The GST activity of the rats’ liver was determined by 
analysing the occurrence of 1-chloro 2,4-dinitrobenzene 
conjugate and glutathione (19). Absorbance was registered 
at 340 nm. The GST activity was described as 
µmol mg protein-1.
Hematological parameters
Blood samples were analysed for red blood (RBC) and 
white blood cell (WBC) counts, hemoglobin, mean 
corpuscular volume (MCV), hematocrit, mean corpuscular 
hemoglobin (MCH), mean corpuscular hemoglobin 
concentration (MCHC), and platelets (PLT) using a Sysmex 
XT-2000i hematology analyser (Sysmex Co., Ltd., Kobe, 
Japan).
Biochemical parameters
Blood samples were taken from the heart and collected 
into sterile tubes. They were then centrifuged at 2000 g and 
the serum was separated. Levels of total protein and 
cholesterol, albumin, triglyceride, activities of aspartate 
aminotransferase, alkaline phosphatase, alanine 
aminotransferase, and lactate dehydrogenase were analysed 
using a commercial spectrophotometer-enzymatic kit.
Determination of DNA damage (Comet assay)
Liver samples for the assessment of DNA damage were 
collected and processed immediately after the rats were 
killed. Tissue was homogenised, transferred into RPMI 
1640 and centrifugated for 5 min. The alkaline comet assay 
was performed using a modified method described by Ozkan 
et al. (20).
Briefly, 150 µL of cell suspension per rat was mixed 
with 75 µL of 0.5 % low-melting point agarose in PBS at 
37 °C. The sample was then pipetted onto a microscope 
slide pre-coated with a layer of 0.6 % normal-melting point 
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agarose. Two replicate slides per each rat were prepared. 
Gel was left to solidify on ice for 10 min. The slides were 
then immersed into a lysis solution (2.5 M NaCl, 100 mM 
Na2EDTA, 10 mM Tris-HCl, 1 % Na-sarcosinate, pH 10 
with 1 % Triton X-100 and 10 % dimethyl sulfoxide) 
overnight. After lysis, the slides were placed in a horizontal 
electrophoresis unit filled with cold freshly prepared 
denaturation/electrophoresis buffer (300 mM NaOH, 1 M 
Na2EDTA, pH 13.0). DNA unwinding lasted for 20 min. 
Electrophoresis was performed for 20 min. at 25 V and 
300 mA. Slides were washed in three changes of 
neutralisation buffer (0.4 M Tris-HCl, pH 7.5) at 5-min. 
intervals. Microgels were stained with ethidium bromide 
(2 µg mL-1). Image analyses were done using BS 200 ProP, 
BAB Imaging System (Ankara, Turkey). Comets were 
captured under an epifluorescence microscope (BAB BS 
200 ProP, Ankara, Turkey) at 20x and 40x magnification.
A total of 100 comets per sample per animal were scored 
randomly and pooled for each group of animals. To estimate 
DNA damage levels, three comet parameters were 
evaluated: tail DNA%, tail length, and tail moment.
Histopathological studies
Liver samples were fixed in formalin solution. They 
were hydrated with increasing ethanol series and embedded 
in paraffin. Sections (5-6 μm) were cut using a microtome 
(Leica RM2255, Germany) and stained with hematoxylin-
eosin (H&E) for histological examinations. The sections 
were viewed and photographed using a light microscope 
(Olympus BX51, Japan) and a camera (Olympus E-330, 
Japan). They were evaluated for the degree of 
histopathological changes.
Statistics
The results of the experiment were expressed as the 
mean±SEM with seven rats in each group. Intergroup 
variation was analysed statistically using one-way analysis 
of variance and software version 20.0 SPSS for Windows, 
followed by a Tukey’s test. Results were considered 
statistically significant when P<0.05.
RESULTS
None of the rats died during the experimental period. 
Blood glucose levels of diabetic rats were 300 mg dL-1 or 
greater throughout the experiment (Table 1).
MDA levels and antioxidant enzyme activities
Diabetes decreased the activities of GPx, SOD, GST, 
and CAT in the liver. Application of furan further decreased 
enzyme activities (Figures 1-4) (P<0.05). We observed an 
increase in the activities when lycopene was applied both 
in the diabetic lycopene and diabetic furan+lycopene groups 
compared with the diabetic control and diabetic furan 
groups, respectively.
Levels of MDA were identified in liver tissues of rats. 
All groups showed an increased MDA level compared to 
controls. We observed more elevated results in the diabetic 
furan group than in the diabetic control group (P<0.05). In 
the diabetic lycopene and diabetic furan+lycopene groups 
we designated the preventive effect of lycopene on the 
inspected parameters (Figure 5).
Hematological parameters
Significant changes were not found in the levels of 
hemoglobin, RBC, hematocrit, MCHC, MCV, and MCH 
when all groups were compared one to the other. At the end 
of the 4th week, when the diabetic control group was 
crosschecked against controls, there was a significant 
increment in WBC and platelet counts. These counts were 
significantly lowered when the diabetic lycopene group was 
compared with the diabetic control. When furan was 
administered to diabetic rats, we observed an increase in 
the changes of WBC and platelets. Lycopene showed 
preventive effects against furan-induced alterations in WBC 
and platelet counts (Table 2).
Figure 1 SOD activities (U mg protein-1) in the liver of rats treated 
with furan (40 mg kg-1 bw) and lycopene. Each bar represents 
mean±SEM of seven animals in each group. Columns superscripted 
with different letters are significantly different. Significance at 
P<0.05
Figure 2 CAT activities (mmol mg protein-1) in the liver of rats 
treated with furan (40 mg kg-1 bw) and lycopene on. Each bar 
represents mean±SEM of seven animals in each group. Columns 
superscripted with different letters are significantly different. 
Significance at P<0.05
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Table 1 Blood glucose levels (mg dL-1) of control and experimental groups
Groups Blood Glucose (mg dL
-1)
day 1 day 14 day 28
Control 96.2±7.7 115.9±14.2 94.6±13.8
Diabetic control 417.8±13.3 421.3±18.6 414.3±20.4
Diabetic lycopene (4 mg kg-1 bw) 381.7±19.2 392.8±10.5 384.3±12.7
Diabetic furan (40 mg kg-1 bw) 408.9±11.2 406.4±13.7 411.5±10.8
Diabetic furan+lycopene 386.2±11.4 401±8.25 397.4±21.6
Values are mean±SEM of seven rats in each group. Significance at P<0.05
Figure 3 GPx activities (nmol mg protein-1) in the liver of rats 
treated with furan (40 mg kg-1 bw) and lycopene on. Each bar 
represents mean±SEM of seven animals in each group. Columns 
superscripted with different letters are significantly different. 
Significance at P<0.05
Figure 4 GST activities (µmol mg protein-1) in the liver of rats 
treated with furan (40 mg kg-1 bw) and lycopene. Each bar 
represents mean±SEM of seven animals in each group. Columns 
superscripted with different letters are significantly different. 
Significance at P<0.05
Hepatic function tests and lipid profile
In the diabetic control group we observed significant 
increases in AST, LDH, ALT, and ALP activities, 
triglyceride, and total cholesterol levels, along with 
decreases in the levels of total protein and albumin as 
compared with the control. When furan was administered 
to diabetic rats, an increase in the levels of the above 
mentioned parameters, except in triglyceride and total 
cholesterol levels was found. Lycopene showed preventive 
effects against both diabetes and furan-induced alterations 
in hepatic function tests but not in the lipid profile (Table 
3).
Histological changes
As revealed by the pathological assessment, both 
diabetes and furan treatment induced liver injury in rats 
(Figure 6). In diabetic rats treated with furan there were 
extensive damages in the liver sections. Eosinophilic 
cytoplasm, vascular congestion, and hemorrhage were 
observed in the diabetic control group. Vascular congestion, 
mononuclear cell infiltration, dilation of sinusoids, 
hemorrhage, degeneration of hepotocytes were observed in 
the liver following furan treatment. In addition, in diabetic 
furan rats, severe histopathological changes were 
determined. Lycopene alleviated the harmful effects of both 
diabetes and furan (Figure 6). Table 4 shows the scores of 
histological alterations in all groups.
Primary DNA damage in liver cells
The mean tail length and tail DNA % significantly 
increased with diabetes and furan treatment. A decrease in 
these values was observed in the diabetic furan+lycopene 
and diabetic lycopene groups compared with the diabetic 
furan and diabetic control groups, respectively (Table 5). 
The types of DNA damage observed using the comet assay 
are shown in Figure 7 for the control and diabetic groups.
DISCUSSION
The comprehensive purpose of our study was to identify 
the effects of furan and lycopene on the liver of diabetic 
rats at the point of oxidative damage.
Data which were obtained from the present study 
ascertained that furan treatment and diabetes caused an 
increase in the activities of ALP, LDH, ALT, and AST of 
rats. In a work by Farokhi et al. (21), increased ALT and 
AST activities were also detected in diabetic rats. This 
increase may be due to liver dysfunction and a breakdown 
in enzyme synthesis which changes the liver’s membrane 
permeability (9). Furan-exposed and diabetic animals also 
revealed lower total protein and albumin levels. The 
albumin level may decrease in rats as a disorder of the liver 
function after furan exposure; there are studies confirming 
that chemicals cause a reduction of albumin and total protein 
levels (22). In previous studies, researchers observed that 
diabetes caused an increase in the serum levels of total 
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Control Diabetic control Diabetic lycopene Diabetic furan
Diabetic 
furan+lycopene
RBC (M mm-3) 7.78±0.98a 8.43±0.68a 7.78±0.98a 8.26±0.78a 8.39±0.57a
Hemoglobin (g dL-1) 15.60±0.89a 14.20±0.54a 14.10±0.68a 14.80±0.55a 14.70±0.95a
Hematocrit (%) 41.30±2.92a 40.40±3.92a 43.10±3.57a 42.20±3.97a 40.82±2.79a
WBC (K mm-3) 5.19±0.37a 8.71±0.22b 7.12±0.31c 9.89±0.46d 8.99±0.24e
MCH (pg) 16.80±2.91a 18.00±1.15a 18.20±1.93a 20.20±3.62a 19.30±2.55a
MCV (fL) 49.90±4.82a 54.28±3.47a 50.95±3.72a 51.65±3.89a 52.71±5.03a
MCHC (g dL-1) 30.44±3.82a 35.16±2.67a 33.13±0.84a 30.48±3.02a 33.18±0.83a
Platelet (K mm-3) 705.27±13.11a 852.17±22.81b 756.13±21.62c 947.52±30.69d 893±13.26e
Values are mean±SEM of seven rats in each group. Significance at P<0.05. Within each column, means superscripted with different 
letters are significantly different
Table 3 Effects of subacute (28 days) treatment with furan (40 mg kg-1 bw) and lycopene (4 mg kg-1 bw) on the liver function tests and 








Total protein (g dL-1) 7.18±0.24a 6.22±0.18b 6.76±0.21c 4.64±0.37d 5.71±0.22e
Albumin (g dL-1) 4.56±0.19a 4.02±0.07b 4.24±0.11c 3.03±0.08d 3.54±0.07e
AST (U L-1) 37.21±1.62a 45.60±1.47b 41.57±2.02c 53.20±3.17d 48.82±1.09e
ALT (U L-1) 5.02±0.27a 7.43±1.14b 5.73±0.31c 9.94±0.59d 8.96±0.33e
ALP (U L-1) 14.08±2.91a 21.08±2.27b 17.92±0.73c 31.22±1.13d 26.81±3.01e
LDH (U L-1) 45.81±3.62a 59.89±2.01b 53.67±4.12c 74.06±5.04d 65.71±3.16e
Triglyceride (mg dL-1) 27.04±3.02a 35.16±2.41b 33.73±2.84b 34.46±3.24b 33.88±1.98b
Total cholesterol (mg dL-1) 702.86±19.71a 822.74±22.38b 801.13±11.55b 837.59±33.71b 835.1±28.76b
Values are mean±SEM of seven rats in each group. Significance at P<0.05. Within each column, means superscripted with different 
letters are significantly different
Figure 5 MDA levels (nmol mg protein-1) in the liver of rats treated 
with furan (40 mg kg-1 bw) and lycopene. Each bar represents 
mean±SEM of seven animals in each group. Columns superscripted 
with different letters are significantly different. Significance at 
P<0.05
cholesterol and triglyceride (23). Thus, increased parameters 
can be due to the effects of diabetes on the permeability of 
membranes of hepatic cells (24). Lycopene showed 
protective effects against furan and diabetes-induced 
changes in hepatic function tests. However, we did not 
determine the effects of furan and lycopene on total 
cholesterol and triglyceride levels.
Chemicals can change hematological parameters (25). 
In the present study, furan and diabetes enhanced WBC 
counts. This increase may point to the activation of the 
immune system of rats (25). The increase in WBC counts 
of animals is in agreement with the data of Mahour and 
Saxena (26). It is clear from our observation that PLT counts 
in rats treated with 40 mg kg-1 body weight of furan differed 
from the control. A significant inrease in PLT counts was 
found in the furan treated group. Chemicals can induce 
histopathological damages (27) and these damages can stir 
up an increase in PLT and WBC counts (22). Our 
histopathological results support this probability in the furan 
treated group. The results obtained from Sultan et al. (28)
indicated that diabetes mellitus imparted negative effects 
on various hematological attributes.
Several studies suggest that oxidative stress appears to 
be the key determinant of toxicity induced by furan and 
diabetes both in vivo and in vitro (29, 30). Recent in vivo 
studies in furan treated animals showed reactive oxygen 
species (ROS) formation and stimulation of lipid 
peroxidation (LPO) promoting the function of oxidative 
stress in the toxicity of furan (31, 32). Furan-caused 
oxidative stress adds substantially to liver injury. Excessive 
ROS and raised LPO are some of the unwanted effects of 
furan (32). An increased MDA level, end product of LPO, 
is a major determinant of LPO (33). Incremental MDA was 
determined in the liver of furan-exposed rats. Selmanoğlu 
et al. (34) also reported enhanced MDA levels in furan 
toxicity in their work.
Mammalian cells have antioxidants and antioxidant 
enzymes to prevent tissues from oxidative damage. 
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Table 4 Grading of the histopathological changes in the liver sections
            Groups
Pathology




cytoplasm - ++ + + +
vascular congestion - ++ + ++ +
hemorrhage - ++ - +++ ++
mononuclear cell 
infiltration
- - - + -
dilation of sinusoids - - - +++ ++
degeneration of 
hepotocytes - - - ++ +
Scoring was done as follows: (-) none, (+) mild, (++) moderate, (+++) severe
Table 5 Effect of furan (40 mg kg-1 bw) and lycopene (4 mg kg-1 bw) on liver DNA damage in non-diabetic and diabetic rats as estimated 
by the alkaline comet assay 
DNA parameters Control Diabetic control Diabetic  Lycopene Diabetic  Furan
Diabetic Furan 
+ Lycopene
Tail DNA (%) 48.80±3.27a 75.77±4.60b 73.06±2.16c 94.06±1.54d 85.34±6.80e
Tail length 16.50±0.71a 67.00±7.78b 42.50±26.16c 147.00±21.26d 52.00±9.90e
Tail moment 8.052±1.02a 31.34±20.03b 73.06±2.16c 138.92±22.21d 44.71±11.98e
Values are mean±SEM of seven rats in each group. Superscripted letters indicate significant differences (P<0.05) among diabetic rats 
exposed to furan and lycopene. Within each column, means superscripted with different letters are significantly different (P<0.05)
Figure 6 (A) Liver section of control rats, CV: central vein 200X. (B) 
Liver sections of diabetic control rats showing (curled arrow) 
eosinophilic cytoplasm, (black arrow) vascular congestion, (>) 
hemorrhage 200X. (C) Liver sections of diabetic lycopene treated rats 
showing (curled arrow) eosinophilic cytoplasm, (black arrow) vascular 
congestion 200X. (D, E) Liver sections of diabetic furan treated rats 
showing (black arrow) vascular congestion, (blue arrow) mononuclear 
cell infiltration, (red arrow) dilation of sinusoids, (>) hemorrhage, (♦) 
degeneration of hepotocytes 200X. (F) Liver sections of diabetic 
furan+lycopene treated rats showing (>) hemorrhage, (red arrow) 
dilation of sinusoids, (black arrow) vascular congestion 200X
Alteration in the activity of antioxidant enzymes can be 
regarded as a sensitive marker of the response of cells to 
oxidative stress (35). Aiming to disclose the effects of furan 
and lycopene, we determined alterations in intracellular 
antioxidant enzyme activities. As crosschecked against the 
control group, treatment of rats with 40 mg kg-1 furan and 
diabetes induced decreases in the enzyme activities of CAT, 
GST, GPx, and SOD. Nevertheless, these decreases were 
reduced by the treatment with lycopene (4 mg kg-1). From 
these data, the changes of the GST, SOD, CAT, and GPx 
activities resulting from the treatment with lycopene clearly 
point to the competence of the defence system of cells to 
respond to an oxidative stress agent. Alterations of 
antioxidant enzyme activities observed in this work may 
be due to the production of ROS. Selmanoğlu et al. (34) 
reported that treatment of rats with furan showed changes 
in antioxidant enzyme activities. Connections between 
chemical treatment and alterations in antioxidant enzyme 
activities have been proven (36).
Microscopic findings in the liver were severe with furan 
treatment and diabetes, similar to the findings in previous 
reports (2, 21, 37). Furan induced vascular congestion, 
mononuclear cell infiltration, dilation of sinusoids, 
hemorrhage, and degeneration of hepatocytes in this study. 
These histopathological changes coincide with alternations 
in biochemical and hematological parameters in the present 
study. Adverse effects of furan have been proven in previous 
studies too. Gill et al. (38) determined that furan induced 
histopathological changes in the liver and kidney. Also, in 
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are more sensitive than diabetic rats without furan treatment. 
This situation is supported by a previous study (45). In 
addition, Apaydin et al. (4) indicated in their study that lead 
nitrate treated diabetic rats were more sensitive than diabetic 
rats without lead nitrate treatment.
In order to overcome the extreme levels of ROS, cells 
have enzymes like SOD, GPx, GST, and CAT. Even so, 
these protective systems cannot exactly oppose the 
destructive effects of ROS (35). Additional antioxidants 
can advance to increase the defence systems of cells. For 
this reason, these antioxidants are necessary to cope with 
excessive ROS production. Recent studies showed that 
lycopene, which is an antioxidant, significantly prevented 
the chemical-induced changes in antioxidant enzyme 
activities, MDA levels, and liver marker enzymes (13, 46). 
In addition, Matos et al. (47) determined in their study that 
oxidative DNA damage was reduced with lycopene 
treatment in rats in vivo and in cell culture. These findings 
are supported in our data. Also, the results showed that 
lycopene substantially decreased the levels of serum hepatic 
function parameters, WBC, and platelet counts in furan and 
diabetes-treated animals and improved the histopathologic 
changes in the liver of rats. Lycopene becomes protective 
towards the examined parameters because of its antioxidant 
properties, like in other studies (46, 48). It may be an 
indirect scavenger of ROS or it can boost antioxidant 
enzyme activities; therefore it may prevent the toxicity 
produced by furan and diabetes. Carotenoids are well known 
scavengers of singlet oxygen and its other excited species. 
During singlet oxygen quenching, energy is transferred 
from singlet oxygen to the lycopene molecule, converting 
it to the energy-rich triplet state. The trapping of other ROS, 
like OH•, NO2• or peroxynitrite, in contrast, leads to 
oxidative breakdown of the lycopene molecule. Thus, 
lycopene may protect in vivo against oxidation of lipids, 
proteins, and DNA (13).
Considering the data obtained from this study we can 
say that furan and diabetes cause liver damages by way of 
oxidative stress. Due to the generation of ROS, both cause 
damage to cell membranes and DNA, as confirmed by the 
comet assay, as well as histopathological alterations. Our 
findings suggest that lycopene applied at the tested 
concentration could protect rat liver against furan and 
diabetes-induced toxicity but not completely. The 
promissing results obtained in this study speak in favour of 
further investigation using other lycopene doses and 
exposure scenarios to prove its usefulness as a cyto/
genoprotective agent.
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a study by Karacaoğlu et al. (39), furan caused harmful 
effects in the pathology of pancreas and adrenal cortex.
Diabetes and complications of diabetes are associated 
with increased oxidative stress (3). Shanmugam et al. (40) 
and Suresh et al. (29) observed that diabetes increased LPO 
and changed antioxidant enzyme activities. There are also 
studies confirming that diabetes causes histological 
alterations in different tissues (40). In this study there are 
alterations in antioxidant enzyme activities, MDA levels, 
haematological, and biochemical parameters in the diabetic 
groups compared to controls. DNA is known to be targeted 
by various chemicals whose activity results in genotoxic 
effects (41, 42). This study was also performed to observe 
the genotoxic potential of furan and the protective role of 
lycopene in liver tissues of diabetic rats. It was observed 
that the tail lengths were elongated with diabetes and furan 
treatment. Furan causes sister chromatid exchanges in vitro 
in Chinese hamster ovary cells and furan exposure induces 
chromosomal aberrations in both Chinese hamster ovary 
cells and B6C3F1 mouse bone marrow cells (43). Diabetes 
induces oxidative stress in cells resulting in the formation 
of toxic products such as MDA and 4-hydroxynonenal. Both 
aldehydes, MDA and 4-hydroxynonenal, can cause 
mitochondrial enzyme damage and DNA breaks. 
4-hydroxynonenal can play roles in toxic pathways such as 
the induction of caspases and the laddering of genomic 
DNA (44). Also, it is clear that furan-treated diabetic rats 
Figure 7 Photomicrographs of liver nuclei observed after the 
alkaline comet assay procedure in rats treated with furan 
(40 mg kg-1 bw) exposure and/or lycopene and in the control group.
(a) control, (b) diabetic control, (c) diabetic lycopene, (d) diabetic 
furan, (e) diabetic furan + lycopene
Stained with ethidium bromide. Photomicrographs have been 
acquired by BS 200 ProP, BAB Imaging System (Ankara, Turkey) 
under magnification 20X (a, b, d, e,) and 40X (c)
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Hepatotoksične i hematološke promjene u dijabetičkih štakora izazvane furanom: zaštitna uloga likopena
Furan se stvara toplinskom obradom hrane i djeluje štetno na organizam. U ovom smo istraživanju dijabetičke mužjake 
štakora tretirali likopenom, furanom i kombinacijom tih dviju tvari tijekom 28 dana. Procijenjene su hematološke promjene, 
ukupne razine proteina, kolesterola, triglicerida i albumina, aktivnosti alanin aminotransferaze, aspartat aminotransferaze, 
laktat dehidrogenaze i alkalne fosfataze u serumu, razine malondialdehida, aktivnosti glutation peroksidaze, katalaze, 
glutation-S-transferaze i superoksid dizmutaze te oštećenje DNA u tkivu jetara i hepatičke histopatološke promjene u 
odnosu na kontrolnu skupinu. Utvrđene su značajne promjene u testovima funkcije jetara, razinama oštećenja DNA, 
aktivnostima antioksidacijskih enzima i razinama malondialdehida između dijabetičke kontrolne skupine i dijabetičke 
skupine tretirane likopenom te između dijabetičke kontrolne skupine i kontrolne skupine bez dijabetesa, između dijabetičke 
kontrolne skupine i dijabetičke skupine tretirane likopenom te između dijabetičke skupine tretirane furanom i dijabetičke 
kontrolne skupine. U dijabetičkoj skupini tretiranoj likopenom i dijabetičkoj skupini tretiranoj i furanom i likopenom 
utvrdili smo preventivne učinke likopena, ali samo u odnosu na analizirane parametre. Unatoč patološkim promjenama 
koje su utvrđene u jetrima dijabetičke skupine tretirane furanom, manje ih je utvrđeno u skupinama koje su tretirane 
furanom i likopenom na kraju četvrtoga tjedna. Zaključak je istraživanja da je likopen značajno smanjio toksičnost koju 
je prouzročio furan i dijabetes u jetrima štakora.
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